Recently, Chen et al. uncovered that the loss of receptor for activated C kinase 1 (RACK1) elicits activation of the AKT/mTOR signaling pathway, upregulating SLC1A5 and fostering glutamine addiction in gastric cancer cells [100]. The gene discussed is AKT1; the disease is gastric cancer.